Physician profile
Suzanne Self
NPI 1063489078
$340.94
in general payments reported to CMS, 2019-2025
8 companies · $50.57 in 2025
The $50.57 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8.24 · 2023: $211 · 2024: $70.87 · 2025: $50.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $72.56 | 2023-2025 | Wegovy, Ozempic |
| Amgen INC. | $69.95 | 2023-2024 | Otezla, Repatha |
| Corcept Therapeutics | $68.10 | 2023-2024 | Korlym |
| Astrazeneca Pharmaceuticals LP | $45.51 | 2023-2024 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $36.70 | 2023-2025 | Mounjaro |
| Mylan Specialty L.P. | $20.23 | 2023 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $19.65 | 2023 | |
| Genentech USA, INC. | $8.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Self listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.